Mission Hospital McDowell

Marion, North Carolina 28752

0 studies enrolling now · 7 studies all time

What they study most

Advanced Adult Hepatocellular Carcinoma, Breast Ductal Carcinoma In Situ, HER2/Neu Positive, Invasive Breast Carcinoma, Lung Cancer, Melanoma of Unknown Primary, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Recurrent Hepatocellular Carcinoma, Recurrent Melanoma

Studies at this site

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer — Running, not enrolling
• Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery — Running, not enrolling
• Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer — Completed
• Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia — Running, not enrolling
• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer — Completed
• Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy — Completed
• Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide — Status unconfirmed